410 related articles for article (PubMed ID: 22221203)
21. Review article: monitoring of immunomodulators in inflammatory bowel disease.
Aberra FN; Lichtenstein GR
Aliment Pharmacol Ther; 2005 Feb; 21(4):307-19. PubMed ID: 15709982
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy and breastfeeding in inflammatory bowel disease.
Biedermann L; Rogler G; Vavricka SR; Seibold F; Seirafi M
Digestion; 2012; 86 Suppl 1():45-54. PubMed ID: 23051726
[TBL] [Abstract][Full Text] [Related]
23. Reproduction in the patient with inflammatory bowel disease.
Selinger CP
Minerva Gastroenterol Dietol; 2013 Sep; 59(3):285-97. PubMed ID: 23867948
[TBL] [Abstract][Full Text] [Related]
24. Management of inflammatory bowel diseases during pregnancy.
Dignass AU; Hartmann F; Sturm A; Stein J
Dig Dis; 2009; 27(3):341-6. PubMed ID: 19786762
[TBL] [Abstract][Full Text] [Related]
25. Fertility and pregnancy in inflammatory bowel disease.
Weterman IT
Neth J Med; 1989 Jun; 35 Suppl 1():S67-75. PubMed ID: 2702315
[TBL] [Abstract][Full Text] [Related]
26. Pregnancy and the Patient with Inflammatory Bowel Disease: Fertility, Treatment, Delivery, and Complications.
McConnell RA; Mahadevan U
Gastroenterol Clin North Am; 2016 Jun; 45(2):285-301. PubMed ID: 27261899
[TBL] [Abstract][Full Text] [Related]
27. Usefulness of co-treatment with immunomodulators in patients with inflammatory bowel disease treated with scheduled infliximab maintenance therapy.
Sokol H; Seksik P; Carrat F; Nion-Larmurier I; Vienne A; Beaugerie L; Cosnes J
Gut; 2010 Oct; 59(10):1363-8. PubMed ID: 20587545
[TBL] [Abstract][Full Text] [Related]
28. My treatment approach to management of the pregnant patient with inflammatory bowel disease.
Ng SW; Mahadevan U
Mayo Clin Proc; 2014 Mar; 89(3):355-60. PubMed ID: 24582194
[TBL] [Abstract][Full Text] [Related]
29. Review article: the benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.
Chouchana L; Narjoz C; Beaune P; Loriot MA; Roblin X
Aliment Pharmacol Ther; 2012 Jan; 35(1):15-36. PubMed ID: 22050052
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive drugs in the treatment of inflammatory bowel disease.
Aranda R; Horgan K
Semin Gastrointest Dis; 1998 Jan; 9(1):2-9. PubMed ID: 9547850
[TBL] [Abstract][Full Text] [Related]
31. Fecundity, pregnancy outcomes, and breastfeeding in patients with inflammatory bowel disease: a large cohort survey.
Mañosa M; Navarro-Llavat M; Marín L; Zabana Y; Cabré E; Domènech E
Scand J Gastroenterol; 2013 Apr; 48(4):427-32. PubMed ID: 23477328
[TBL] [Abstract][Full Text] [Related]
32. Drug therapy of inflammatory bowel disease in fertile women.
Kroser J; Srinivasan R
Am J Gastroenterol; 2006 Dec; 101(12 Suppl):S633-9. PubMed ID: 17177868
[TBL] [Abstract][Full Text] [Related]
33. Review article: practical management of inflammatory bowel disease patients taking immunomodulators.
Siegel CA; Sands BE
Aliment Pharmacol Ther; 2005 Jul; 22(1):1-16. PubMed ID: 15963074
[TBL] [Abstract][Full Text] [Related]
34. Management of inflammatory bowel disease in pregnancy.
Ng SW; Mahadevan U
Expert Rev Clin Immunol; 2013 Feb; 9(2):161-73; quiz 174. PubMed ID: 23390947
[TBL] [Abstract][Full Text] [Related]
35. Review article: the management of Crohn's disease and ulcerative colitis during pregnancy and lactation.
Schulze H; Esters P; Dignass A
Aliment Pharmacol Ther; 2014 Nov; 40(9):991-1008. PubMed ID: 25200000
[TBL] [Abstract][Full Text] [Related]
36. Inflammatory bowel disease therapy: current state-of-the-art.
Blonski W; Buchner AM; Lichtenstein GR
Curr Opin Gastroenterol; 2011 Jul; 27(4):346-57. PubMed ID: 21654383
[TBL] [Abstract][Full Text] [Related]
37. Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.
Su C; Lichtenstein GR
Gastroenterol Clin North Am; 2004 Jun; 33(2):209-34, viii. PubMed ID: 15177535
[TBL] [Abstract][Full Text] [Related]
38. Clinical trial: benefits and risks of immunomodulators and maintenance infliximab for IBD-subgroup analyses across four randomized trials.
Lichtenstein GR; Diamond RH; Wagner CL; Fasanmade AA; Olson AD; Marano CW; Johanns J; Lang Y; Sandborn WJ
Aliment Pharmacol Ther; 2009 Aug; 30(3):210-26. PubMed ID: 19392858
[TBL] [Abstract][Full Text] [Related]
39. Drug therapy for inflammatory bowel disease in pregnancy and the puerperium.
Moffatt DC; Bernstein CN
Best Pract Res Clin Gastroenterol; 2007; 21(5):835-47. PubMed ID: 17889811
[TBL] [Abstract][Full Text] [Related]
40. Review article: the effects of antitumour necrosis factor-α on bone metabolism in inflammatory bowel disease.
Veerappan SG; O'Morain CA; Daly JS; Ryan BM
Aliment Pharmacol Ther; 2011 Jun; 33(12):1261-72. PubMed ID: 21521250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
